Increased CCL2 production has also been described in several pathological conditions, mainly autoimmune disorders such as diabetes, atherosclerosis, rheumatoid arthritis, multiple sclerosis and in a wide variety of solid cancers (72). This evidence concerns the gene CCL2 and rheumatoid arthritis.